Over the last 20 years, the incidence of prostate cancer has increased in Europe due to the introduction in the late 1980s of the use of the prostate specific antigen (PSA) test for screening, which allows the detection of more cases [6]. The gene discussed is KLK3; the disease is prostate cancer.